Collaborate with GenQual
Eliminating exposure to non-response cohorts protects the patient from deleterious adverse events and improves the drug safety profile.
From 2003 to 2009 he served at gene therapy pioneer Targeted Genetics Corp. as Sr. Quality Control Analyst. He primarily specialized in assay transfer, optimization, and validation of various analytical methods including bioassay, infectious titer, replication-competent virus, ELISA, and qPCR, using statistical analysis in support of clinical trials. Mr. Mirich formerly served as a Research Technician at the Genito-Urinary Cancer Research Laboratory at the University of Washington. He attended Seattle Pacific University, Dept. of Biology.
His scientific research included the exploration of genetic polymorphisms linked to the transmission of vector-borne diseases such as malaria. Dr. Colton earned a Ph.D. from the University of Notre Dame and a J.D. from Brigham Young University.
Dr. Paul received his Ph.D. in Molecular Virology at University of Calgary and he performed his post-doc studies in retrovirology at Oregon Health and Science University School of Medicine.